[HTML][HTML] Ablative therapy for people with localised prostate cancer: a systematic review and economic evaluation.

CR Ramsay, TE Adewuyi, J Gray, J Hislop… - Health Technology …, 2015 - ncbi.nlm.nih.gov
BACKGROUND For people with localised prostate cancer, active treatments are effective but
have significant side effects. Minimally invasive treatments that destroy (or ablate) either the …

ASCENDE-RT: an analysis of treatment-related morbidity for a randomized trial comparing a low-dose-rate brachytherapy boost with a dose-escalated external beam …

S Rodda, S Tyldesley, WJ Morris, M Keyes… - International Journal of …, 2017 - Elsevier
Purpose To report the genitourinary (GU) and gastrointestinal (GI) morbidity and erectile
dysfunction in a randomized trial comparing 2 methods of dose escalation for high-and …

Prostate cancer, version 2.2014

JL Mohler, PW Kantoff, AJ Armstrong… - Journal of the National …, 2014 - jnccn.org
Prostate cancer has surpassed lung cancer as the most common cancer in men in the
United States. The NCCN Guidelines for Prostate Cancer provide multidisciplinary …

[HTML][HTML] Prostate cancer: ESMO consensus conference guidelines 2012

A Horwich, J Hugosson, T de Reijke, T Wiegel… - Annals of oncology, 2013 - Elsevier
Abstract The first ESMO Consensus Conference on prostate cancer was held in Zurich,
Switzerland, on 17–19 November 2011, with the participation of a multidisciplinary panel of …

Permanent interstitial low-dose-rate brachytherapy for patients with localised prostate cancer: a systematic review of randomised and nonrandomised controlled …

F Peinemann, U Grouven, C Bartel, S Sauerland… - European urology, 2011 - Elsevier
CONTEXT: Prostate cancer (PCa) is the most common cancer in men. Permanent interstitial
low-dose-rate brachytherapy (LDR-BT) is a short-distance radiation therapy in which low …

The effectiveness of intensity modulated radiation therapy versus three-dimensional radiation therapy in prostate cancer: a meta-analysis of the literatures

T Yu, Q Zhang, T Zheng, H Shi, Y Liu, S Feng, M Hao… - PloS one, 2016 - journals.plos.org
Background and Purpose Intensity modulated radiation therapy (IMRT) can deliver higher
doses with less damage of healthy tissues compared with three-dimensional radiation …

Comparison of tumor control and toxicity outcomes of high-dose intensity-modulated radiotherapy and brachytherapy for patients with favorable risk prostate cancer

MJ Zelefsky, Y Yamada, X Pei, M Hunt, G Cohen… - Urology, 2011 - Elsevier
OBJECTIVES: To compare the long-term, prostate-specific antigen relapse-free survival
outcome and incidence of toxicity for patients with low-risk prostate cancer who underwent …

Brachytherapy improves biochemical failure–free survival in low-and intermediate-risk prostate cancer compared with conventionally fractionated external beam …

GD Smith, T Pickles, J Crook, AG Martin… - International Journal of …, 2015 - Elsevier
Purpose To compare, in a retrospective study, biochemical failure-free survival (bFFS) and
overall survival (OS) in low-risk and intermediate-risk prostate cancer patients who received …

Does the planning dose–volume histogram represent treatment doses in image-guided prostate radiation therapy? Assessment with cone-beam computerised …

JA Hatton, PB Greer, C Tang, P Wright, A Capp… - Radiotherapy and …, 2011 - Elsevier
PURPOSE: To assess the accuracy of the initial CT plan dose–volume histograms (DVH's)
for prostate, rectum and bladder by comparison to delivered doses determined from cone …

Deep learning‐based dominant index lesion segmentation for MR‐guided radiation therapy of prostate cancer

J Simeth, J Jiang, A Nosov, A Wibmer… - Medical …, 2023 - Wiley Online Library
Background Dose escalation radiotherapy enables increased control of prostate cancer
(PCa) but requires segmentation of dominant index lesions (DIL). This motivates the …